The study of the efficacy of rivastigmin in cognitive status of schizophrenic patients
Phase 2
- Conditions
- F20-F29Schizophrenia.Schizophrenia, schizotypal and delusional disorders
- Registration Number
- IRCT201110083010N3
- Lead Sponsor
- Kermanshah University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Inclusive criteria: 1) the diagnosis of schizophrenia made by the psychiatrist based on DSM.IV.TR; 1) the presence of some cognitive deficits; 3) being volunteer to participate in the study; 4) being under treatment with atypical antipsychotic medications. Exclusion criteria: 1) disagreement to participate in the study; 2) treatment with typical antipsychotic agents; 3) absence of any of inclusive criteria; 4) concordance of substance dependence disorders; 5) co-morbidity with organic mental disorders.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive status. Timepoint: The week 0 and week 12. Method of measurement: MMSE questionnaire.
- Secondary Outcome Measures
Name Time Method Improvement of cognitive status. Timepoint: The weeks 0 and 12. Method of measurement: MMSE questionnaire.